Nigeria Country Profile

Nigeria country flag

Nigeria Country Profile

Discover more about CDC’s work in Nigeria by viewing our detailed country profile

Country Overview

Established in 2001, CDC’s Nigeria office provides technical leadership and assistance to the Ministry of Health and implementing partners to strategically scale-up HIV and tuberculosis (TB) testing, treatment, and prevention; build in-country capacity for high-quality national laboratory services; and strengthen epidemiology, disease surveillance, laboratory, blood safety, operations research, and workforce capacity. Additionally, CDC provides technical guidance to ensure that TB/HIV collaborative activities, as well as TB infection control programs, are strengthened.

Per Capita GNI



Population (million)



Under 5 Mortality

113.8/1,000 Live Births


Life Expectancy

55 Years


Estimated HIV Prevalence


(Ages 15-49): (2021)

Estimated AIDS Deaths


(Age≥15) (2021)

TB Treatment Success Rate



Estimated TB Incidence



Estimated Orphans Due to AIDS



TB patients with known HIV-status who are HIV-positive



Reported Number Receiving Antiretroviral Therapy (ART)


(Age≥15) (2021)

Strategic Focus

Active Strategic Scale-up of Comprehensive HIV Services: The Centers for Disease Control and Prevention (CDC) office in Nigeria was established in February 2001, and provides technical leadership and assistance to the Ministry of Health (MOH) and implementing partners to scale up HIV testing, treatment, and prevention of mother-to-child transmission of HIV (PMTCT) services.

Strengthening Laboratory Systems and Networks: CDC provides technical leadership and assistance to build in-country capacity for high-quality HIV and Tuberculosis (TB) diagnostic and monitoring, and to support the development of a national reference public health laboratory system for HIV, TB, and other diseases.

Strengthening Public Health Systems: CDC assists the MOH to strengthen epidemiology, surveillance, laboratory, medical informatics, operations research, and workforce capacity – essential components for a strong, sustainable public health system.

Key Activities and Accomplishments

Prevention of Mother-to-Child HIV Transmission (PMTCT) Support: Working with local stakeholders and partners, 1,702 sites offering PMTCT services were established between October 2016 and September 2017. According to PEPFAR Nigeria data, between October 2016 and September 2017, HIV testing and counseling were provided to about 1 million pregnant women and antiretroviral therapy (ART) to 24,445 HIV-positive pregnant women to prevent mother-to-child transmission.

HIV Testing Services (HTS) and Antiretrovirus Treatment (ART) Services: CDC, through its implementing partners, provides high quality HIV testing services and HIV treatment and support services. Between October 2016 and September 2017, CDC and its partners provided HIV testing services to about 5 million people across Nigeria. Of this, 109,275 were diagnosed with HIV infection and referred for treatment. (PEPFAR Nigeria, 2017) At the end of FY17 (September 30, 2017), 480,207 patients were receiving ART, while almost 250,000 Orphan and Vulnerable Children were provided with a minimum of one care service in the last quarter of FY17. (PEPFAR Nigeria, 2017)

TB/HIV Integration: CDC continues to provide technical guidance to partners to ensure TB/HIV collaborative activities are strengthened. Between October 2016 and September 2017, CDC supported partners screened about 477,921 people living with HIV for TB signs and symptoms; 4,452 TB patients were diagnosed with HIV and placed on ART HIV therapy. (PEPFAR Nigeria, 2017)

TB Infection Prevention and Control: CDC scaled up a comprehensive TB infection control program called TB BASICS across all PEPFAR supported facilities in Nigeria. The ongoing TB BASICS program helps protect healthcare workers and patients from healthcare-associated infection from TB and other airborne infection, and the MOH has incorporated TB BASICS into the national TB/HIV training modules for Healthcare workers.

National AIDS Impact & Indicator Survey (NAIIS):  CDC, through its implementing partner University of Maryland (UMB), is carrying out the largest HIV impact survey (target sample size = 170,000) in the country’s history to measure HIV burden and viral suppression nationally and at each of Nigeria 36 states and the Federal Capital Territory.

group of men marching

Large national survey shows smaller HIV epidemic in Nigeria

The Government of Nigeria, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), CDC, and the University of Maryland School of Medicine released new data from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS), one of the largest population-based HIV/AIDS household surveys ever conducted.

social media card. photo, healthcare worker and patient

Social Media Card

TB is the #1 killer of people living with HIV. TB preventative treatment protects those with HIV from contracting TB Disease. It’s effective, It’s affordable. It saves lives.

social media card. photo, boy looking up

Social Media Card

CDC study provides new evidence that Drug-Resistant Tuberculosis is set to rise in some of the world’s highest burden countries and suggests that it will increasingly be transmitted from Person to Person

Page last reviewed: September 30, 2021, 12:00 AM